Digital twins for multiple sclerosis
I Voigt, H Inojosa, A Dillenseger, R Haase… - Frontiers in …, 2021 - frontiersin.org
An individualized innovative disease management is of great importance for people with
multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional …
multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional …
Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review
L Lakin, BE Davis, CC Binns, KM Currie… - Neurology and therapy, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
Digital biomarkers in multiple sclerosis
A Dillenseger, ML Weidemann, K Trentzsch, H Inojosa… - Brain sciences, 2021 - mdpi.com
For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …
the preservation of quality of life play a crucial role over the entire therapy period. In MS …
Harnessing real-world data to inform decision-making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS
PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper …
PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper …
Associations of sNfL with clinico‐radiological measures in a large MS population
ES Sotirchos, KC Fitzgerald, CM Singh… - Annals of Clinical …, 2023 - Wiley Online Library
Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐
throughput assays on widely accessible platforms in large, real‐world MS populations, is a …
throughput assays on widely accessible platforms in large, real‐world MS populations, is a …
Association of disease severity and socioeconomic status in Black and White Americans with multiple sclerosis
K Gray-Roncal, KC Fitzgerald, LZ Ryerson, L Charvet… - Neurology, 2021 - AAN Enterprises
Objective To compare clinical and imaging features of multiple sclerosis (MS) severity
between Black Americans (BAs) and White Americans (WAs) and to evaluate the role of …
between Black Americans (BAs) and White Americans (WAs) and to evaluate the role of …
Artificial Intelligence and Multiple Sclerosis
M Amin, E Martínez-Heras, D Ontaneda… - Current Neurology and …, 2024 - Springer
In this paper, we analyse the different advances in artificial intelligence (AI) approaches in
multiple sclerosis (MS). AI applications in MS range across investigation of disease …
multiple sclerosis (MS). AI applications in MS range across investigation of disease …
Telehealth in multiple sclerosis clinical care and research
XM Xiang, J Bernard - Current neurology and neuroscience reports, 2021 - Springer
Abstract Purpose of Review The COVID-19 pandemic has provided us with a unique
opportunity to experiment with telehealth and evaluate its benefits and limitations. This …
opportunity to experiment with telehealth and evaluate its benefits and limitations. This …
Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort
KC Fitzgerald, A Damian, D Conway… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Objective: The objective of this study is to assess the association between vascular
comorbidity burden with clinical and imaging features of disease burden in a large …
comorbidity burden with clinical and imaging features of disease burden in a large …
Depression in multiple sclerosis across the adult lifespan
Objectives: The objective of this study is to examine the burden of depressive symptoms
across the adult age span in people with multiple sclerosis (MS) and test if the relationship …
across the adult age span in people with multiple sclerosis (MS) and test if the relationship …